Description

Glucuronolactone, a naturally occurring metabolite of glucose, is widely used in China as a liver-protective aid, especially for acute and chronic hepatitis, early liver fibrosis, and detoxification. Also known as “Gantaile,” it enhances glucuronidation, detoxifies phenolic/toxic metabolites, reduces glycogen breakdown, and supports collagen synthesis.

Yunpeng’s formulation provides a convenient, lab-ready tablet used in hepatotoxicity, liver metabolism, and detox mechanism studies, paralleling its clinical applications.

Product Specifications

Mechanism of Action

Glucuronolactone is readily converted into glucuronic acid in the body, enhancing phase II detoxification—conjugating with phenolic, hydroxyl, or amino toxins for urinary excretion. It also reduces glycogen breakdown, boosts hepatic glycogen storage, and supports collagen and connective tissue synthesis—critical for liver repair .

Research Applications

• Models of acute and chronic hepatitis

• Hepatocyte detoxification assays via glucuronidation pathway

• Oxidative stress and liver enzyme regulation studies

• Early-stage liver fibrosis and metabolic recovery research

Safety & Handling

• Intended for laboratory research only—not for clinical or veterinary use

• Generally well-tolerated; occasional mild GI symptoms may be noted

• Store sealed, handle with standard PPE

• Discard if tablets show discoloration or signs of degradation

Core Keywords

glucuronolactone tablets, Yunpeng Gantaile, CAS 32449-92-6, hepatoprotective glucuronolactone, liver detox tablet, acute hepatitis research, chronic hepatitis support, glucuronidation liver compound, NMPA H14020789

Research Use Disclaimer

This product is strictly for laboratory/preclinical research. It is not approved for diagnostic, therapeutic, veterinary, or clinical use. Misuse may involve health or regulatory risks. Always follow institution-level protocols.